Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H18NO2P |
Molecular Weight | 179.1971 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCNC(C)(C)P(O)=O
InChI
InChIKey=WCXWARPXYQCRPP-UHFFFAOYSA-N
InChI=1S/C7H18NO2P/c1-4-5-6-8-7(2,3)11(9)10/h8,11H,4-6H2,1-3H3,(H,9,10)
Butafosfan is a phosphororganic supplement that is given, most commonly with cyanocobalamin, to cattle, swine, horses, and poultry for the prevention or treatment of phosphorus deficiencies. Butafosfan also plays a vital role in hepatic carbohydrate metabolism. In addition, butafosfan has been regarded as an antistress agent in combination with vitamin B12. Studies with butafosfan in different animals have shown that it improved general health status by stimulating feed intake, immune system, and digestive function. Butafosfan has been reported for the treatment of metabolic disorders caused by stress or nutrition problems in various species.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21943742
Cows: 10 ml/100 kg
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29730
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
||
|
WHO-VATC |
QA12CX91
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
241-341-7
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
CHEMBL1979022
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
SUB05997MIG
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
4312
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
DTXSID5048681
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
72084
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
C73233
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
3Q2LQ1149L
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
819929
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000088475
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
3Q2LQ1149L
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY | |||
|
17316-67-5
Created by
admin on Fri Dec 15 16:26:39 GMT 2023 , Edited by admin on Fri Dec 15 16:26:39 GMT 2023
|
PRIMARY |
ACTIVE MOIETY